Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Esther, Broset"'
Autor:
David Luna-Cerralbo, Irene Blasco-Machín, Susana Adame-Pérez, Verónica Lampaya, Ana Larraga, Teresa Alejo, Juan Martínez-Oliván, Esther Broset, Pierpaolo Bruscolini
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 23, Iss , Pp 3050-3064 (2024)
The concept of “codon optimisation” involves adjusting the coding sequence of a target protein to account for the inherent codon preferences of a host species and maximise protein expression in that species. However, there is still a lack of cons
Externí odkaz:
https://doaj.org/article/aac216204ea849e7a516a78851084c03
Autor:
Boaro, Andreia, Ageitos, Lucía, Torres, Marcelo Der Torossian, Blasco, Esther Broset, Oztekin, Sebahat, de la Fuente-Nunez, Cesar
Publikováno v:
In Cell Reports Physical Science 19 July 2023 4(7)
Autor:
Esther Broset, Juan Calvet Seral, Carmen Arnal, Santiago Uranga, Alex I. Kanno, Luciana C.C. Leite, Carlos Martín, Jesús Gonzalo-Asensio
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss , Pp 4273-4283 (2021)
Live vaccines are attractive vehicles for antigen delivery as a strategy to immunize against heterologous pathogens. The live vaccine MTBVAC is based on rational attenuation of Mycobacterium tuberculosis with the objective of improving BCG protection
Externí odkaz:
https://doaj.org/article/a0aa4c6c152b42498f9386a4963c14ed
Autor:
Esther Broset, Narcís Saubi, Núria Guitart, Nacho Aguilo, Santiago Uranga, Athina Kilpeläinen, Yoshiki Eto, Tomáš Hanke, Jesús Gonzalo-Asensio, Carlos Martín, Joan Joseph-Munné
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss , Pp 253-264 (2019)
The tuberculosis (TB) vaccine MTBVAC is the only live-attenuated Mycobacterium tuberculosis (Mtb)-based vaccine in clinical development, and it confers superior protection in different animal models compared to the current vaccine, BCG (Mycobacterium
Externí odkaz:
https://doaj.org/article/4a25bf7bef1a4aa7909cc3e9194b2412
Autor:
Esther Broset, Jacobo Pardo-Seco, Alex I. Kanno, Nacho Aguilo, Ana Isabel Dacosta, Irene Rivero-Calle, Jesus Gonzalo-Asensio, Camille Locht, Luciana C.C. Leite, Carlos Martin, Federico Martinón-Torres
Publikováno v:
EBioMedicine, Vol 65, Iss , Pp 103254- (2021)
Background: The Bacillus Calmette-Guérin (BCG), the only vaccine against tuberculosis (TB) currently in use, has shown beneficial effects against unrelated infections and to enhance immune responses to vaccines. However, there is little evidence reg
Externí odkaz:
https://doaj.org/article/cae65a52f6424aab9984632c9bf74420
Autor:
Jorge Guío, Esther Broset, M. Luisa Peleato, Emma Sevilla, Cristina Sarasa-Buisan, María F. Fillat
Publikováno v:
Environmental Microbiology. 24:566-582
FurC (PerR) from Anabaena sp. PCC7120 was previously described as a key transcriptional regulator involved in setting off the oxidative stress response. In the last years, the cross-talk between oxidative stress, iron homeostasis and nitrogen metabol
Autor:
Carmen Arnal, Esther Broset, Carlos Martin, Jesús Gonzalo-Asensio, Santiago Uranga, Alex I. Kanno, Juan Calvet Seral, Luciana C. C. Leite
Publikováno v:
Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 4273-4283 (2021)
Computational and Structural Biotechnology Journal
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Computational and Structural Biotechnology Journal
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Graphical abstract
Live vaccines are attractive vehicles for antigen delivery as a strategy to immunize against heterologous pathogens. The live vaccine MTBVAC is based on rational attenuation of Mycobacterium tuberculosis with the objective of
Live vaccines are attractive vehicles for antigen delivery as a strategy to immunize against heterologous pathogens. The live vaccine MTBVAC is based on rational attenuation of Mycobacterium tuberculosis with the objective of
Publikováno v:
mBio, Vol 6, Iss 5 (2015)
ABSTRACT Different members of the Mycobacterium genus have evolved to cause tuberculosis in diverse human populations and in a variety of animal species. Our cumulative knowledge of mycobacterial genomes indicates that mutations in the PhoPR two-comp
Externí odkaz:
https://doaj.org/article/dc68ad2f42ef426fa0c0e7ef283f2033
Publikováno v:
Trends in Immunology. 40:952-973
The gut microbiome has a significant impact on health and disease and can actively contribute to obesity, diabetes, inflammatory bowel disease, cardiovascular disease, and neurological disorders. We do not yet have the necessary tools to fine-tune th
Autor:
Núria Guitart, Yoshiki Eto, Joan Joseph-Munné, Athina Kilpeläinen, Nacho Aguilo, Esther Broset, Tomáš Hanke, Carlos Martin, Narcís Saubi, Jesús Gonzalo-Asensio, Santiago Uranga
Publikováno v:
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss, Pp 253-264 (2019)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Molecular Therapy-Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 13, Iss, Pp 253-264 (2019)
Zaguán. Repositorio Digital de la Universidad de Zaragoza
instname
Molecular Therapy-Methods & Clinical Development
The tuberculosis (TB) vaccine MTBVAC is the only live-attenuated Mycobacterium tuberculosis (Mtb)-based vaccine in clinical development, and it confers superior protection in different animal models compared to the current vaccine, BCG (Mycobacterium